Federal Register / Vol. 60, No. 86 / Thursday, May 4, 1995 / Notices 22067

financial futures and options on

futures); and Societe Generale, 76

Federal Reserve Bulletin 776 (1990).

Deutsche Bank maintains that Futures

would conduct these previously

approved activities in conformance with

the conditions and limitations

established by the Board in prior cases.

In order to approve the proposal, the

Board must determine that the proposed

activities to be conducted by Deutsche

Bank and Futures ‘‘can reasonably be

expected to produce benefits to the

public, such as greater convenience,

increased competition, or gains in

efficiency, that outweigh possible

adverse effects, such as undue

concentration of resources, decreased or

unfair competition, conflicts of

interests, or unsound banking

practices.’’ 12 U.S.C. 1843(c)(8).

Deutsche Bank believes that the

proposal will produce public benefits

that outweigh any potential adverse

effects. In particular, Deutsche Bank

maintains that the proposal will

enhance competition and enable

Deutsche Bank to assist its customers in

lowering financing costs, contributing to

greater market stability, increasing

efficiency and reducing portfolio risk. In

addition, Deutsche Bank states that the

proposed activities will not result in

adverse effects such as an undue

concentration of resources, decreased or

unfair competition, conflicts of interest,

or unsound banking practices.

In publishing the proposal for

comment, the Board does not take a

position on issues raised by the

proposal. Notice of the proposal is

published solely to seek the views of

interested persons on the issues

presented by the application and does

not represent a determination by the

Board that the proposal meets, or is

likely to meet, the standards of the BHC

Act.

Any comments or requests for hearing

should be submitted in writing and

received by William W. Wiles,

Secretary, Board of Governors of the

Federal Reserve System, Washington,

D.C. 20551, not later than May 18, 1995

. Any request for a hearing on this

application must, as required by §

262.3(e) of the Board’s Rules of

Procedure (12 CFR 262.3(e)), be

accompanied by a statement of the

reasons why a written presentation

would not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

This application may be inspected at

the offices of the Board of Governors or

the Federal Reserve Bank of New York.

Board of Governors of the Federal

Reserve System, April 28, 1995.

Jennifer J. Johnson

Deputy Secretary of the Board.

[FR Doc. 95–11038 Filed 5–3–95; 8:45 am]

BILLING CODE 6210–01–F

Societe Generale; Notice of

Application to Engage de novo in

Permissible Nonbanking Activities

The company listed in this notice has

filed an application under § 225.23(a)(1)

of the Board’s Regulation Y (12 CFR

225.23(a)(1)) for the Board’s approval

under section 4(c)(8) of the Bank

Holding Company Act (12 U.S.C.

1843(c)(8)) and § 225.21(a) of Regulation

Y (12 CFR 225.21(a)) to commence or to

engage de novo, either directly or

through a subsidiary, in a nonbanking

activity that is listed in § 225.25 of

Regulation Y as closely related to

banking and permissible for bank

holding companies. Unless otherwise

noted, such activities will be conducted

throughout the United States.

The application is available for

immediate inspection at the Federal

Reserve Bank indicated. Once the

application has been accepted for

processing, it will also be available for

inspection at the offices of the Board of

Governors. Interested persons may

express their views in writing on the

question whether consummation of the

proposal can ‘‘reasonably be expected to

produce benefits to the public, such as

greater convenience, increased

competition, or gains in efficiency, that

outweigh possible adverse effects, such

as undue concentration of resources,

decreased or unfair competition,

conflicts of interests, or unsound

banking practices.’’ Any request for a

hearing on this question must be

accompanied by a statement of the

reasons a written presentation would

not suffice in lieu of a hearing,

identifying specifically any questions of

fact that are in dispute, summarizing the

evidence that would be presented at a

hearing, and indicating how the party

commenting would be aggrieved by

approval of the proposal.

Comments regarding the application

must be received at the Reserve Bank

indicated or the offices of the Board of

Governors not later than May 18, 1995.

A. Federal Reserve Bank of New

York (William L. Rutledge, Senior Vice

President) 33 Liberty Street, New York,

New York 10045:

1. Societe Generale, Paris, France; to

engage de novo through its subsidiary,

Societe Generale Asset Management

Corp., New York, New York, in

nonbanking activities acting as

investment or financial advisor,

pursuant to § 225.25(b)(4) of the Board’s

Regulation Y. These activities will be

conducted worldwide.

Board of Governors of the Federal Reserve

System, April 28, 1995.

Jennifer J. Johnson,

Deputy Secretary of the Board.

[FR Doc. 95–11039 Filed 5–3–95; 8:45 am]

BILLING CODE 6210–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Food Advisory Committee;

Cancellation

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is cancelling the

subcommittee meeting of the Food

Advisory Committee scheduled for May

8 and 9, 1995, to provide time for the

agency to expand its ongoing research

review. The meeting was announced in

the Federal Register of April 21, 1995

(60 FR 19949). It is anticipated that the

meeting will be rescheduled in the

future, to be announced at a later date

in the Federal Register.

FOR FURTHER INFORMATION CONTACT:

Lynn A. Larsen, Center for Food

Safety and Applied Nutrition (HFS–

5), Food and Drug Administration,

200 C St. SW., Washington, DC

20204, 202–205–4727,

Catherine M. DeRoever, Advisory

Committee Staff (HFS–22), 200 C St.

SW., Washington, DC 20204, 202–

205–4251, or

FDA Advisory Committee Information

Hotline, 1–800–741–8138 (301–

443–0572 in the Washington, DC

area), Food Advisory Committee,

code 10564.

Dated: May 1, 1995.

Linda A. Suydam,

Interim Deputy Commissioner for Operations.

[FR Doc. 95–11169 Filed 5–2–95; 2:25 pm]

BILLING CODE 4160–01–F

Health Care Financing Administration

Hearing: Reconsideration of

Disapproval of Illinois State Plan

Amendment (SPA)

AGENCY: Health Care Financing

Administration (HCFA), HHS.
22068 Federal Register / Vol. 60, No. 86 / Thursday, May 4, 1995 / Notices

ACTION: Notice of hearing.

SUMMARY: This notice announces an

administrative hearing on June 14, 1995,

at 10 a.m. in the 15th Floor Conference

Room, 105 West Adams, Chicago,

Illinois to reconsider our decision to

disapprove Illinois SPA 93–14.

CLOSING DATE: Requests to participate in

the hearing as a party must be received

by the presiding officer by May 19,

1995.

FOR FURTHER INFORMATION CONTACT: Stan

Katz, Presiding Officer, Ground floor,

Meadowwood East Building, 1849

Gwynn Oak Avenue, Baltimore,

Maryland 21207, Telephone: (410) 597–

3013.

SUPPLEMENTARY INFORMATION: This

notice announces an administrative

hearing to reconsider our decision to

disapprove Illinois State plan

amendment (SPA) number 93–14.

Section 1116 of the Social Security

Act (the Act) and 42 CFR part 430

establish Department procedures that

provide an administrative hearing for

reconsideration of a disapproval of a

State plan or plan amendment. The

Health Care Financing Administration

(HCFA) is required to publish a copy of

the notice to a State Medicaid agency

that informs the agency of the time and

place of the hearing and the issues to be

considered. If we subsequently notify

the agency of additional issues that will

be considered at the hearing, we will

also publish that notice.

Any individual or group that wants to

participate in the hearing as a party

must petition the presiding officer

within 15 days after publication of this

notice, in accordance with the

requirements contained at 42 CFR

430.76(b)(2). Any interested person or

organization that wants to participate as

amicus curiae must petition the

presiding officer before the hearing

begins in accordance with the

requirements contained at 42 CFR

430.76(c). If the hearing is later

rescheduled, the presiding officer will

notify all participants.

The State of Illinois submitted SPA

93–14 on October 18, 1994, to establish

a new payment adjustment for

uncompensated care services, and

requested an effective date of July 1,

1993.

The issue in this matter is whether

Illinois SPA 93–14, meets Federal

regulations which require the State to

comply with the public notice

requirements in Section 447.205.

Illinois published public notice on

August 6, 1993, with the plan

amendment’s proposed effective date of

July 1, 1993.

HCFA believes the proposed effective

date of the plan amendment was not

approvable because the State failed to

comply with the Federal regulation at

42 CFR 447.253(h) which requires that

the Medicaid agency must comply with

public notice requirements in § 447.205

when it is proposing significant changes

to its methods and standards for setting

payment rates for inpatient hospital and

long-term care facility services. Section

447.225(d)(1) requires that the notice be

published before the proposed effective

date of the change. The State’s requested

effective date is prior to the date of the

public notice announcement.

However, because public notice was

published on August 5, 1993, HCFA

believes the plan amendment was

approvable with an effective date of

August 6, 1993.

The State of Illinois contends that the

change was not significant.

Additionally, Illinois challenges HCFA’s

disapproval because public notice was

published prior to the State’s

implementation of the amendment, and

because the eventual disallowances of

Federal financial participation funds

based on public notice requirements are

the subject of current regulatory reform

proposals.

Under HCFA’s policy, the sole factor

in determining a significant change is

the degree to which the State is

proposing to modify its payment

methods and standards. HCFA believes

since this amendment established a new

payment adjustment for uncompensated

care services, the amendment represents

a significant change in the methods and

standards used to determine payment

rates.

The notice to Illinois announcing an

administrative hearing to reconsider the

disapproval of its SPA reads as follows:

Mr. Robert W. Wright,

Director, Illinois Department of Public Aid,

Jesse B. Harris Building II, 3rd Floor, 100

South Grand Avenue, East, Springfield,

Illinois 62762–0001

Dear Mr. Wright: I am responding to your

request for reconsideration of the decision to

disapprove Illinois State Plan Amendment

(SPA) 93–14. The State of Illinois submitted

SPA 93–14 on October 18, 1994, to establish

a new payment adjustment for

uncompensated care services, and requested

an effective date of July 1, 1993.

The issue in this matter is whether Illinois

SPA 93–14, meets Federal regulations at 42

CFR 447.253(h) which require the State to

comply with the public notice requirements

in section 447.205.

I am scheduling a hearing on your request

for reconsideration to be held on June 14,

1995, at 10 a.m. in the 15th floor conference

room, 105 West Adams, Chicago, Illinois. If

this date is not acceptable, we would be glad

to set another date that is mutually agreeable

to the parties. The hearing will be governed

by the procedures prescribed at 42 CFR, Part

430.

I am designating Mr. Stanley Katz as the

presiding officer. If these arrangements

present any problems, please contact the

presiding officer. In order to facilitate any

communication which may be necessary

between the parties to the hearing, please

notify the presiding officer to indicate

acceptability of the hearing date that has

been scheduled and provide the names of the

individuals who will represent the State at

the hearing. The presiding officer may be

reached at (410) 597–3013.

Sincerely,

Bruce C. Vladeck,

Administrator.

(Sec. 1116 of the Social Security Act (42

U.S.C. section 1316); 42 CFR 430.18)

(Catalog of Federal Domestic Assistance

Program No. 13.714, Medicaid Assistance

Program)

Dated: April 28, 1995.

Bruce C. Vladeck,

Administrator, Health Care Financing

Administration.

[FR Doc. 95–11019 Filed 5–3–95; 8:45 am]

BILLING CODE 4120–01–P

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS,

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and